PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-10-18

Date Title Company
18-Oct-2024 How to Choose the Best Canadian Online Pharmacy Network That Will Ship to the United States AccessWire
18-Oct-2024 ProductLife Group (PLG) Acquires Halloran to Further Expand Its Global Reach and Capabilities to Support the Development of New Therapies ProductLife Group (PLG)
18-Oct-2024 OncoZenge AB intends to enter partnership with Pharmanovia for commercialization of BupiZenge™ in Europe, Middle East & North Africa OncoZenge AB
18-Oct-2024 Johnson & Johnson transitions Remicade® (infliximab) and Simponi® (golimumab) for treatment of patients with Inflammatory Diseases Johnson & Johnson
18-Oct-2024 Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials Medidata
18-Oct-2024 LEARN ABOUT TREATING AND MANAGING DEMENTIA AT A SPECIAL WEBINAR EVENT Luye Pharma Ltd
18-Oct-2024 Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress Biognosys
18-Oct-2024 Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024 Medigene AG
18-Oct-2024 ProductLife Group (PLG) Acquires Halloran to Further Expand Its Global Reach and Capabilities to Support the Development of New Therapies ProductLife Group
18-Oct-2024 NHS report shows an increase in HRT item prescriptions the NHS Business Services Authority (NHSBSA)
18-Oct-2024 Fortrea Releases Inaugural Corporate Social Responsibility Report Fortrea
18-Oct-2024 eXmoor and Virica receive funding to improve AAV gene therapy manufacturing eXmoor pharma
18-Oct-2024 AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services AscellaHealth LLC
18-Oct-2024 Terumo Blood and Cell Technologies kicks off U.S. launch of Reveos Automated Blood Processing System with Blood Centers of America Terumo Blood and Cell Technologies
18-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Inc
18-Oct-2024 Menopause in Aesthetics (MiA) announces their headline sponsor as Roseway Labs for their third year running. Menopause in Aesthetics (MiA)
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi
18-Oct-2024 PUBLICATION DEMONSTRATES POTENTIAL FOR MULTI-MARKER CTC PROFILING IN EARLY PROSTATE CANCER ANGLE plc
18-Oct-2024 Yourgene Health Cystic Fibrosis Base Assay Receives IVDR Accreditation Yourgene Health
18-Oct-2024 SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878 SciRhom GmbH